Expert Roundtable: Comorbidities in Atopic Dermatitis
Atopic dermatitis, especially severe atopic dermatitis, is associated with allergic, autoimmune, and cardiovascular comorbidities.
Dermatitis
DERMATITIS
FEATURE ARTICLE
LATEST NEWS
PO SCORAD for Black Skin a Valuable Tool for Evaluating AD
PO-SCORAD for black skin is a simple tool that allows patients to easily self-assess atopic dermatitis severity. It may prove a valuable tool for monitoring disease severity between physician visits and involving patients in the management of their disease.
Pharmacotherapy Trends for Atopic Dermatitis in the US
Although the atopic dermatitis treatment patterns found reflect existing clinical guidelines, second-generation antihistamines are not recommended in the management of atopic dermatitis, despite being the third most prescribed medication class.
Dupilumab Induces Rapid Improvement of Atopic Dermatitis in Japanese Adults
Data from this analysis indicate that dupilumab induces rapid improvements in AD that can be maintained long term in a significant percentage of Japanese adults with moderate to severe AD, with prolonged benefits in terms of both pruritus and QoL.
Moderate to Severe Atopic Dermatitis Associated With Increased Risk for Atrial Fibrillation
The study data showed a 20% increased long-term risk for atrial fibrillation in patients with hospital-diagnosed moderate to severe atopic dermatitis.
Abrocitinib Effective in Second Phase 3 Atopic Dermatitis Trial
Pfizer announced positive topline results from the phase 3 JADE MONO-2 trial of abrocitinib, an oral Janus kinase 1 inhibitor, for the treatment of moderate to severe atopic dermatitis.
Dupilumab Associated With Favorable Benefit/Risk Ratio for Treatment of Atopic Dermatitis, Phase 3 Safety Data Indicates
This study supports the use of dupilumab as a systemic treatment for long-term management of moderate to severe AD without routine laboratory monitoring in clinical practice.
Higher Self-Reported Severity of AD Indicative of Lower Health-Related Quality of Life
From the patient’s perspective, higher atopic dermatitis severity is associated with poorer HRQoL — a burden that may provide motivation for more effective management of atopic dermatitis.
Dupilumab Shows Significant Clinical Improvement for Atopic Dermatitis Across Racial Subgroups
Notable improvement with dupilumab in the treatment of moderate to severe atopic dermatitis was seen in all racial subgroups.
Temperature, Humidity May Enhance Relationship Between Air Pollution and Atopic Dermatitis
Study findings suggest that temperature, relative humidity, and air pollution are significantly associated with outpatient visits for atopic dermatitis.
Practice Gaps in Pediatric Atopic Dermatitis Reveal Need for Uniform, Effective Care
Treatment varies greatly for pediatric patients with atopic dermatitis as drugs with known risks continue to be popular and beneficial agents are rarely prescribed.
Want to read more?
Please login or register first to view this content.
Next post in Dermatitis
